INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 116 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $88,000 | -40.9% | 25,263 | +114.7% | 0.00% | -60.0% |
| Q2 2017 | $149,000 | -71.4% | 11,767 | -76.3% | 0.01% | -68.8% |
| Q1 2017 | $521,000 | +33.6% | 49,589 | +16.9% | 0.02% | +60.0% |
| Q4 2016 | $390,000 | +146.8% | 42,405 | +216.5% | 0.01% | +150.0% |
| Q3 2016 | $158,000 | -79.2% | 13,398 | -49.5% | 0.00% | -81.0% |
| Q4 2015 | $759,000 | +44.0% | 26,517 | +43.1% | 0.02% | +16.7% |
| Q3 2015 | $527,000 | +4.6% | 18,532 | +32.1% | 0.02% | +20.0% |
| Q2 2015 | $504,000 | +89.5% | 14,030 | +207.0% | 0.02% | +66.7% |
| Q1 2015 | $266,000 | -49.3% | 4,570 | -63.3% | 0.01% | -50.0% |
| Q4 2014 | $525,000 | -39.5% | 12,448 | -44.4% | 0.02% | -41.9% |
| Q3 2014 | $868,000 | +57.8% | 22,394 | +27.1% | 0.03% | +47.6% |
| Q2 2014 | $550,000 | – | 17,626 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
| Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
| Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
| SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
| Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
| JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
| TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
| GAM Holding AG | 83,940 | $745,000 | 0.03% |
| Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |